...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Gasoline
5
Jan 23, 2017 07:19PM
3
Jan 30, 2017 12:57PM
2
Jan 30, 2017 01:31PM
3
Jan 30, 2017 02:31PM
1
Jan 30, 2017 07:44PM

Jan 30, 2017 07:57PM
2
Jan 30, 2017 08:34PM
4
Jan 30, 2017 09:29PM

Jan 30, 2017 10:46PM
5
Jan 31, 2017 10:52AM
4
Jan 31, 2017 03:03PM
4
Feb 03, 2017 09:32PM
3
Feb 04, 2017 03:04PM
3
Feb 05, 2017 01:11PM
2
Feb 05, 2017 06:56PM
3
Feb 05, 2017 08:21PM
3
Feb 09, 2017 12:30PM

Tuesday 2/14 Zenith has a 15 minute presentation at BIO CEO & Investor Conference. Of course, these types of conferences often come and go with nothing new, but maybe next week is different. Resverlogix also has a presentation (30 minutes) at this conference on 2/14 as well. Neither one is to be webcast, per Sarah. However, maybe they will post the slides.

BearDownAZ

Share
New Message
Please login to post a reply